Abstract: CancerVolume 64, Issue 11 p. 2387-2392 ArticleFree Access Malignant lymphomas of bone in Japan Takafumi Ueda MD, Takafumi Ueda MD Department of Pathology, Osaka University Medical School, Osaka, JapanSearch for more papers by this authorKatsuyuki Aozasa MD, Corresponding Author Katsuyuki Aozasa MD Department of Pathology, Nara Medical University, Kashihara, JapanNara Medical University, Department of Pathology, Shijo-Cho 840, Kashihara 634, Japan===Search for more papers by this authorMasahiko Ohsawa MD, Masahiko Ohsawa MD Department of Pathology, Nara Medical University, Kashihara, JapanSearch for more papers by this authorHideki Yoshikawa MD, Hideki Yoshikawa MD Department of Orthopedic Surgery, Osaka University Medical School, Osaka, JapanSearch for more papers by this authorAtsumasa Uchida MD, Atsumasa Uchida MD Department of Orthopedic Surgery, Osaka University Medical School, Osaka, JapanSearch for more papers by this authorKeiro Ono MD, Keiro Ono MD Department of Orthopedic Surgery, Osaka University Medical School, Osaka, JapanSearch for more papers by this authorKeishi Matsumoto MD, Keishi Matsumoto MD Department of Pathology, Osaka University Medical School, Osaka, JapanSearch for more papers by this author Takafumi Ueda MD, Takafumi Ueda MD Department of Pathology, Osaka University Medical School, Osaka, JapanSearch for more papers by this authorKatsuyuki Aozasa MD, Corresponding Author Katsuyuki Aozasa MD Department of Pathology, Nara Medical University, Kashihara, JapanNara Medical University, Department of Pathology, Shijo-Cho 840, Kashihara 634, Japan===Search for more papers by this authorMasahiko Ohsawa MD, Masahiko Ohsawa MD Department of Pathology, Nara Medical University, Kashihara, JapanSearch for more papers by this authorHideki Yoshikawa MD, Hideki Yoshikawa MD Department of Orthopedic Surgery, Osaka University Medical School, Osaka, JapanSearch for more papers by this authorAtsumasa Uchida MD, Atsumasa Uchida MD Department of Orthopedic Surgery, Osaka University Medical School, Osaka, JapanSearch for more papers by this authorKeiro Ono MD, Keiro Ono MD Department of Orthopedic Surgery, Osaka University Medical School, Osaka, JapanSearch for more papers by this authorKeishi Matsumoto MD, Keishi Matsumoto MD Department of Pathology, Osaka University Medical School, Osaka, JapanSearch for more papers by this author First published: 1 December 1989 https://doi.org/10.1002/1097-0142(19891201)64:11<2387::AID-CNCR2820641132>3.0.CO;2-1Citations: 33AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Abstract Thirty-four cases of primary non-Hodgkin's lymphoma (NHL) of bone collected from hospitals in Japan were histologically and immunohistologically reviewed, and the results were compared with those in Western countries. There were no remarkable differences in age, sex, and the distribution of bone tumors between Japanese and Western cases. Sixteen cases (47%) diagnosed previously as "reticulum cell sarcoma" were reclassified as diffuse NHL of large cell (seven cases), mixed type (four cases), immunoblastic type (three cases), clear cell type (one case), and multilobated type (one case). The cases with small lymphocytic type with plasmacytoid features (lymphoplasmacytic type) were more common in Japan (35% of our cases) than in Western countries. The distribution of histologic subtypes, except for lymphoplasmacytic and T-cell lymphomas, in the current cases was similar to that in Western countries. However, immunohistochemistry showed that Japanese cases contained a much higher frequency of T-cell lymphoma (10% of all cases) than Western cases. Histologic grade according to the Working Formulation correlated well with clinical stage. There may be a tendency towards better prognosis with lower grade tumors, but this was not statistically significant. References 1 Oberling C. Les Reticulosarcomes et les reticuloendotheliosarcomes de la moelle osseuse (sarcomes d'Ewing). Bull Assoc Fr Etude Cancer (Paris) 1928; 17: 259–296. Google Scholar 2 Parker F Jr, Jackson H Jr Primary reticulum cell sarcoma of bone. Surg Gynecol Obstet 1939; 68: 45–53. Google Scholar 3 Lennert K. Malignant lymphomas other than Hodgkin's disease. In: O Lubarsch, F Henke, eds. Histology, Cytology, Ultrastructure, Immunology. Berlin: Springer-Verlag, 1978; 83–110. Google Scholar 4 The Non-Hodgkin's Lymphoma Pathologic Classification Project National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a Working Formulation for clinical usage. Cancer 1982; 49: 2112–2135. 10.1002/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2 PubMedGoogle Scholar 5 Dosoretz DE, Raymond AK, Murphy GF et al. Primary lymphoma of bone: The relationship of morphologic diversity to clinical behavior. Cancer 1982; 50: 1009–1014. 10.1002/1097-0142(19820901)50:5<1009::AID-CNCR2820500532>3.0.CO;2-0 CASPubMedWeb of Science®Google Scholar 6 Ostrowski ML, Unni KK, Banks PM et al. Malignant lymphoma of bone. Cancer 1986; 58: 2646–2655. 10.1002/1097-0142(19861215)58:12<2646::AID-CNCR2820581217>3.0.CO;2-U CASPubMedWeb of Science®Google Scholar 7 Clayton F, Butler JJ, Ayala AG et al. Non-Hodgkin's lymphoma in bone: Pathologic and radiologic features with clinical correlates. Cancer 1987; 60: 2494–2501. 10.1002/1097-0142(19871115)60:10<2494::AID-CNCR2820601025>3.0.CO;2-M CASPubMedWeb of Science®Google Scholar 8 Reimer RR, Chabner BA, Young RC et al. Lymphoma presenting in bone: Results of histopathology, staging and therapy. Ann Intern Med 1977; 87: 50–55. 10.7326/0003-4819-87-1-50 CASPubMedWeb of Science®Google Scholar 9 Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29: 252–260. 10.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-# CASPubMedWeb of Science®Google Scholar 10 Aozasa K, Tsujimoto M, Sakurai M et al. Non-Hodgkin's lymphomas in Osaka, Japan. Eur J Cancer Clin Oncol 1985; 21: 487–492. 10.1016/0277-5379(85)90042-2 CASPubMedWeb of Science®Google Scholar 11 The T- and B-cell Malignancy Study Group. Statistical analysis of immunologic, clinical and histopathologic data on lymphoid malignancies in Japan. Jpn J Clin Oncol 1981; 11: 15–38. Web of Science®Google Scholar 12 Lukes RJ, Taylor CR, Chir B et al. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin's lymphomas and related leukemias. Am J Pathol 1978; 90: 461–486. CASPubMedWeb of Science®Google Scholar 13 Japanese Pathological Society, ed Annuals of the Pathologic Autopsy Cases in Japan (1974–1987). Google Scholar 14 Linder J, Ye L, Harrington DS et al. Monoclonal antibodies marking T lymphocytes in paraffin-embedded tissue. Am J Pathol 1987; 127: 1–8. CASPubMedWeb of Science®Google Scholar 15 Ng CS, Chan JKC, Hui PK et al. Monoclonal antibodies reactive with normal and neoplastic T cells in paraffin sections. Hum Pathol 1988; 19: 295–303. 10.1016/S0046-8177(88)80522-7 CASPubMedWeb of Science®Google Scholar 16 Poppema S, Hollema H, Visser L et al. Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with lymphocyte subsets in paraffin-embedded tissue sections. Am J Pathol 1987; 127: 418–429. PubMedWeb of Science®Google Scholar 17 Takami T, Ishii Y, Yuasa H, Kikuchi K. Three distinct antigen systems on human B cell subpopulations as defined by monoclonal antibodies. J Immunol 1985; 134: 828–834. CASPubMedWeb of Science®Google Scholar 18 Yamabe H. Personal communication. 1989. Google Scholar 19 Carbone PP, Kaplan HS, Musshoff K et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860–1861. CASPubMedWeb of Science®Google Scholar 20 Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481. 10.1002/cncr.21979 CASWeb of Science®Google Scholar 21 Peto R, Pike MC, Armitage NE et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 1977; 35: 1–39. 10.1038/bjc.1977.1 CASPubMedWeb of Science®Google Scholar 22 Dahlin DC. Bone Tumors. Springfield, IL: Thomas, 1978; 173–189. Google Scholar 23 Aozasa K, Inoue A, Tajima K et al. Malignant lymphomas of the thyroid gland: Analysis of 79 patients with emphasis on histologic prognostic factors. Cancer 1986; 58: 100–104. 10.1002/1097-0142(19860701)58:1<100::AID-CNCR2820580118>3.0.CO;2-1 CASPubMedWeb of Science®Google Scholar 24 Maeda H, Sasaki R, Kimoto H et al. Intermediate lymphocytic lymphoma of the salivary gland. Cancer 1988; 62: 203–205. 10.1002/1097-0142(19880701)62:1<203::AID-CNCR2820620130>3.0.CO;2-6 PubMedWeb of Science®Google Scholar 25 Aozasa K, Ueda T, Kurata A et al. Prognostic value of histologic and clinical factors in 56 patients with gastrointestinal lymphomas. Cancer 1988; 61: 309–315. 10.1002/1097-0142(19880115)61:2<309::AID-CNCR2820610221>3.0.CO;2-J PubMedWeb of Science®Google Scholar 26 Nonomura N, Aozasa K, Ueda T et al. Malignant lymphoma of the testis: Histological and immunohistological study of 28 cases. J Urol 1989; 141: 1368–1371. 10.1016/S0022-5347(17)41310-3 CASPubMedWeb of Science®Google Scholar 27 Ostrow S, Diggs CH, Sutherland J et al. Causes of death in patients with non-Hodgkin's lymphoma. Cancer 1981; 48: 779–782. 10.1002/1097-0142(19810801)48:3<779::AID-CNCR2820480320>3.0.CO;2-3 CASPubMedWeb of Science®Google Scholar 28 Hinuma Y. Association of retrovirus (ATLV) with adult T cell leukemia: Review of serologic studies. Gann Monogr Cancer Res 1982; 28: 211–218. Google Scholar Citing Literature Volume64, Issue111 December 1989Pages 2387-2392 ReferencesRelatedInformation